Vanguard Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$161M Buy
7,987,664
+277,538
+4% +$5M ﹤0.01% 1246
2026
Q2
$133M Buy
7,710,126
+125,092
+2% +$1.71M ﹤0.01% 1392
2026
Q1
$94.3M Buy
+7,585,034
New +$102M ﹤0.01% 1499

Other funds holding AMRX

Vanguard Capital Management's AMRX Position: Q3 2026 in Review

Vanguard Capital Management increased its Amneal Pharmaceuticals (AMRX) stake by 3.6% in Q3 2026, buying an estimated $5M and bringing the position to 7,987,664 shares worth $161M. The position accounts for ﹤0.01% of the portfolio, ranked #1246.

Vanguard Capital Management first reported a position in AMRX in Q1 2026 and has held it in 3 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Vanguard Capital Management held 7,987,664 shares of Amneal Pharmaceuticals worth $161M as of Q3 2026.
  • Vanguard Capital Management bought 277,538 Amneal Pharmaceuticals shares in Q3 2026, an estimated $5M.
  • Amneal Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1246 holding.
  • Vanguard Capital Management first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.